Xenon Pharmaceuticals (XENE) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Xenon Pharmaceuticals (XENE) over the last 13 years, with Q3 2025 value amounting to -$1.15.
- Xenon Pharmaceuticals' EPS (Weighted Average and Diluted) fell 4197.53% to -$1.15 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.89, marking a year-over-year decrease of 3794.33%. This contributed to the annual value of -$3.01 for FY2024, which is 1019.39% down from last year.
- As of Q3 2025, Xenon Pharmaceuticals' EPS (Weighted Average and Diluted) stood at -$1.15, which was down 4197.53% from -$1.07 recorded in Q2 2025.
- In the past 5 years, Xenon Pharmaceuticals' EPS (Weighted Average and Diluted) ranged from a high of -$0.35 in Q1 2022 and a low of -$1.15 during Q3 2025
- In the last 5 years, Xenon Pharmaceuticals' EPS (Weighted Average and Diluted) had a median value of -$0.64 in 2023 and averaged -$0.69.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first crashed by 8000.0% in 2023, then skyrocketed by 158.73% in 2024.
- Xenon Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.48 in 2021, then fell by 18.75% to -$0.57 in 2022, then fell by 12.28% to -$0.64 in 2023, then plummeted by 59.55% to -$1.02 in 2024, then fell by 12.62% to -$1.15 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$1.15 for Q3 2025, versus -$1.07 for Q2 2025 and -$0.83 for Q1 2025.